Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AK12
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 32 | 36 | PF00656 | 0.665 |
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.560 |
CLV_NRD_NRD_1 | 154 | 156 | PF00675 | 0.494 |
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.449 |
CLV_NRD_NRD_1 | 242 | 244 | PF00675 | 0.554 |
CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.583 |
CLV_PCSK_FUR_1 | 121 | 125 | PF00082 | 0.549 |
CLV_PCSK_KEX2_1 | 117 | 119 | PF00082 | 0.560 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.572 |
CLV_PCSK_KEX2_1 | 135 | 137 | PF00082 | 0.590 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.494 |
CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.453 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.561 |
CLV_PCSK_PC1ET2_1 | 123 | 125 | PF00082 | 0.565 |
CLV_PCSK_PC1ET2_1 | 135 | 137 | PF00082 | 0.602 |
CLV_PCSK_PC1ET2_1 | 169 | 171 | PF00082 | 0.453 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.648 |
DOC_CKS1_1 | 226 | 231 | PF01111 | 0.657 |
DOC_CYCLIN_yClb3_PxF_3 | 110 | 118 | PF00134 | 0.487 |
DOC_USP7_UBL2_3 | 135 | 139 | PF12436 | 0.580 |
DOC_WW_Pin1_4 | 175 | 180 | PF00397 | 0.518 |
DOC_WW_Pin1_4 | 225 | 230 | PF00397 | 0.666 |
LIG_14-3-3_CanoR_1 | 12 | 22 | PF00244 | 0.574 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.528 |
LIG_BRCT_BRCA1_1 | 177 | 181 | PF00533 | 0.369 |
LIG_eIF4E_1 | 86 | 92 | PF01652 | 0.561 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.658 |
LIG_FHA_1 | 68 | 74 | PF00498 | 0.669 |
LIG_FHA_2 | 144 | 150 | PF00498 | 0.466 |
LIG_FHA_2 | 226 | 232 | PF00498 | 0.542 |
LIG_GBD_Chelix_1 | 91 | 99 | PF00786 | 0.560 |
LIG_LIR_Gen_1 | 134 | 144 | PF02991 | 0.511 |
LIG_LIR_Gen_1 | 146 | 156 | PF02991 | 0.498 |
LIG_LIR_Gen_1 | 16 | 26 | PF02991 | 0.732 |
LIG_LIR_Gen_1 | 83 | 93 | PF02991 | 0.570 |
LIG_LIR_Nem_3 | 134 | 140 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 146 | 151 | PF02991 | 0.477 |
LIG_LIR_Nem_3 | 16 | 22 | PF02991 | 0.585 |
LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.566 |
LIG_LIR_Nem_3 | 83 | 89 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 94 | 99 | PF02991 | 0.438 |
LIG_SH2_CRK | 137 | 141 | PF00017 | 0.493 |
LIG_SH2_CRK | 96 | 100 | PF00017 | 0.480 |
LIG_SH2_SRC | 207 | 210 | PF00017 | 0.638 |
LIG_SH2_STAP1 | 148 | 152 | PF00017 | 0.487 |
LIG_SH2_STAP1 | 56 | 60 | PF00017 | 0.554 |
LIG_SH2_STAT3 | 11 | 14 | PF00017 | 0.680 |
LIG_SH2_STAT5 | 195 | 198 | PF00017 | 0.638 |
LIG_SH2_STAT5 | 227 | 230 | PF00017 | 0.541 |
LIG_SH2_STAT5 | 241 | 244 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.543 |
LIG_SH3_3 | 107 | 113 | PF00018 | 0.476 |
LIG_SH3_3 | 25 | 31 | PF00018 | 0.709 |
LIG_SUMO_SIM_anti_2 | 230 | 236 | PF11976 | 0.454 |
LIG_TYR_ITAM | 83 | 99 | PF00017 | 0.567 |
LIG_TYR_ITIM | 84 | 89 | PF00017 | 0.497 |
MOD_CK2_1 | 225 | 231 | PF00069 | 0.525 |
MOD_CK2_1 | 95 | 101 | PF00069 | 0.340 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.669 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.604 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.610 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.354 |
MOD_PKA_2 | 218 | 224 | PF00069 | 0.714 |
MOD_Plk_1 | 182 | 188 | PF00069 | 0.539 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.463 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.567 |
MOD_ProDKin_1 | 175 | 181 | PF00069 | 0.517 |
MOD_ProDKin_1 | 225 | 231 | PF00069 | 0.663 |
TRG_DiLeu_BaEn_1 | 87 | 92 | PF01217 | 0.554 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.494 |
TRG_ENDOCYTIC_2 | 148 | 151 | PF00928 | 0.476 |
TRG_ENDOCYTIC_2 | 156 | 159 | PF00928 | 0.420 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.501 |
TRG_ENDOCYTIC_2 | 96 | 99 | PF00928 | 0.480 |
TRG_ER_diArg_1 | 117 | 119 | PF00400 | 0.560 |
TRG_ER_diArg_1 | 153 | 155 | PF00400 | 0.504 |
TRG_ER_diArg_1 | 245 | 247 | PF00400 | 0.585 |
TRG_NLS_MonoExtC_3 | 242 | 247 | PF00514 | 0.589 |
TRG_Pf-PMV_PEXEL_1 | 189 | 193 | PF00026 | 0.608 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3B4 | Leptomonas seymouri | 78% | 84% |
A0A0S4J2A8 | Bodo saltans | 46% | 76% |
A0A1X0NL02 | Trypanosomatidae | 61% | 92% |
A0A3S5H594 | Leishmania donovani | 96% | 80% |
A4H3V0 | Leishmania braziliensis | 90% | 100% |
A4HS25 | Leishmania infantum | 96% | 97% |
C9ZY18 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 90% |
Q9BLQ5 | Leishmania major | 94% | 100% |
V5ATQ3 | Trypanosoma cruzi | 63% | 93% |